Skip to main content
AIDS (London, England)
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events.
Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa.
Contributions of HIV, HCV, and traditional vascular risk factors to peripheral artery disease in women.
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results.
Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.
Poverty stigma is associated with suboptimal HIV care and treatment outcomes among women living with HIV in the U.S.
